Safety Study of Repeat Doses of SUSTOL in Adults

Clinical trial NCT05434663 · UNKNOWN

Trial details

NCT number: NCT05434663
Sponsor: Heron Therapeutics
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Chemotherapy-Induced Nausea and Vomiting (CINV)

Start date: 2022-07-06
Primary completion: 2025-10-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.